GlaxoSmithKline
GSK
#215
Rank
ยฃ72.48 B
Marketcap
ยฃ35.79
Share price
-1.82%
Change (1 day)
31.07%
Change (1 year)

GlaxoSmithKline (GSK) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ15.92 Billion

According to GlaxoSmithKline's latest financial reports the company has ยฃ15.92 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ13.08 B2.27%
2023-12-31$ยฃ12.79 B26.73%
2022-12-31$ยฃ10.09 B-52.69%
2021-12-31$ยฃ21.34 B2.57%
2020-12-31$ยฃ20.80 B13.35%
2019-12-31$ยฃ18.35 B399.92%
2018-12-31$ยฃ3.67 B5.25%
2017-12-31$ยฃ3.48 B-29.7%
2016-12-31$ยฃ4.96 B-44.1%
2015-12-31$ยฃ8.87 B79.86%
2014-12-31$ยฃ4.93 B-36.82%
2013-12-31$ยฃ7.81 B15.96%
2012-12-31$ยฃ6.73 B-23.68%
2011-12-31$ยฃ8.82 B-9.42%
2010-12-31$ยฃ9.74 B-9.28%
2009-12-31$ยฃ10.74 B29.14%
2008-12-31$ยฃ8.31 B-16.14%
2007-12-31$ยฃ9.91 B2.85%
2006-12-31$ยฃ9.64 B27.43%
2005-12-31$ยฃ7.56 B23.11%
2004-12-31$ยฃ6.14 B-27.28%
2003-12-31$ยฃ8.45 B14.43%
2002-12-31$ยฃ7.38 B-12.02%
2001-12-31$ยฃ8.39 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
ยฃ34.56 B 117.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ70.00 B 339.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ39.03 B 145.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ33.65 B 111.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ64.89 B 307.52%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
ยฃ5.45 B-65.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
ยฃ0.40 B-97.48%๐Ÿ‡บ๐Ÿ‡ธ USA